NP38625 Compounded Aseptic Medicines

A Tender Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source
Find a Tender
Type
Framework (Supply)
Duration
3 year
Value
£22M
Sector
HEALTH
Published
30 Jul 2025
Delivery
To 31 Aug 2028 (est.)
Deadline
01 Sep 2025 12:00

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 2 buyers and 0 suppliers

2 buyers

Description

Supply of Compounded Aseptic Medicines to NHS Scotland.

Lot Division

1 Compounded Aseptic Medicines
  • Value: £11M

The Authority intends to award this Lot as a single supplier framework. Molecules included within this Lot are as follows: CARBOPLATIN CETUXIMAB CYCLOPHOSPHAMIDE PEMBROLIZUMAB Full details of Goods and volumes can be found within the ITT documents.

Award Criteria
Product Stability 10.0
Communication 10.0
Capacity 10.0
Contingency 10.0
PRICE 60.0
2 Compounded Aseptic Medicines
  • Value: £6M

The Authority intends to award this Lot as a single supplier framework. Molecules included within this Lot are as follows: EPIRUBICIN FLUOROURACIL IRINOTECAN METHOTREXATE NIVOLUMAB RITUXIMAB Full details of Goods and volumes can be found within the ITT documents.

Award Criteria
Product Stability 10.0
Communication 10.0
Capaccity 10.0
Contingency 10.0
PRICE 60.0
3 Compounded Aseptic Medicines
  • Value: £3M

The Authority intends to award this Lot as a single supplier framework. Molecules included within this Lot are as follows: BORTEZOMIB CISPLATIN DOCETAXEL DOXORUBICIN GEMCITABINE INFLIXIMAB OXALIPLATIN TRASTUZUMAB VINCRISTINE Full details of Goods and volumes can be found within the ITT documents.

Award Criteria
Product Stability 10.0
Communication 10.0
Capacity 10.0
Contingency 10.0
PRICE 60.0
4 Compounded Aseptic Medicines
  • Value: £1M

The Authority intends to award this Lot as an un-ranked multi supplier framework to a maximum of three (3) Framework Participants. Molecules included within this Lot are as follows: BEVACIZUMAB CYTARABINE FLUOROURACIL PRE-FILLED PUMPS INSULIN METHOTREXATE NATALIZUMAB PACLITAXEL PANITUMUMAB TRASTUZUMAB VEDOLIZUMAB Full details of Goods and volumes can be found within the ITT documents.

Award Criteria
Product Stability 10.0
Communication 10.0
Capacity 10.0
Contingency 10.0
PRICE 60.0

Renewal Options

This framework includes the option to extend for any number of periods, up to a maximum overall period of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Bids should cover one or more lots.
  • Bids should cover the whole contract.
  • Renewals are available.
  • Financial restrictions apply.
  • Professional qualifications are sought.
  • Award on basis of price.

Other Information

The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the thirty-six (36) month contract duration and the twelve (12) month extension period of the framework agreement. The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 29062. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343 A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363 Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-pr... A summary of the expected community benefits has been provided as follows: It is a mandatory requirement that potential framework participants agree to support the concept, provision, and ongoing development of community benefits provision in relation to this framework. Potential framework participants are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved. Potential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this framework if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits. For further information please visit NHSS Community Benefit Gateway (https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-com...). (SC Ref:803114)

Reference

Domains